Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study)
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|21 Nov 2017||Submitted||Original manuscript|
|27 Dec 2017||Author responded||Author comments - Taro Iguchi|
|Resubmission - Version 2|
|27 Dec 2017||Submitted||Manuscript version 2|
|26 Jul 2018||Reviewed||Reviewer Report - Rahul Aggarwal|
|19 Jan 2019||Reviewed||Reviewer Report - Laurence Krieger|
|6 Feb 2019||Author responded||Author comments - Taro Iguchi|
|Resubmission - Version 3|
|6 Feb 2019||Submitted||Manuscript version 3|
|20 Mar 2019||Reviewed||Reviewer Report - Laurence Krieger|
|25 Mar 2019||Author responded||Author comments - Taro Iguchi|
|Resubmission - Version 4|
|25 Mar 2019||Submitted||Manuscript version 4|
|27 Mar 2019||Editorially accepted|
|11 Apr 2019||Article published||10.1186/s12885-019-5526-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.